Volpara is a digital health company focused on the early detection of breast cancer by improving the quality of screening.
• We have ~40 FTE, mostly based in Wellington & the USA
• Original technology concepts and founders out of Oxford
• Regulatory cleared, clinically validated with patents & trademarks
• Total orders over US$9M since 2009 & installs in 35 countries
• Growing annual recurring revenues (ARR): ~600% growth over last year, we will exceed 200% growth this year.
To view Presentation please download PDF attached:
Download this document
